seed
Stage
1
Investors
About
PureIMS develops Cyclops®, a cost-effective, pre-filled dry powder inhaler that uses patients' breath to deliver powder medications deep into the lungs, targeting respiratory conditions such as cystic fibrosis.
Explore PureIMS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.